GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | October 09, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
5E34 | C4P282 | Crystal structure of H5 hemagglutinin mutant (N224K, Q226L, N158D and L133a deletion) from the influenza virus A/chicken/Vietnam/NCVD-093/2008 (H5N1) with LSTa | |
5E35 | C4P282 | Crystal structure of H5 hemagglutinin mutant (N224K, Q226L, N158D and L133a deletion) from the influenza virus A/chicken/Vietnam/NCVD-093/2008 (H5N1) with LSTc | |
8DUA | C4NR77 | SIV E660.CR54 SOS-2P Env Trimer with ITS92.02 | |
8JFZ | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E1.Mg2+ state. | |
7WYU | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by ATP | |
7WYV | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by ATP in the presence of 40 mM Mg2+ | |
7WYW | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by inorganic phosphate | |
7WYX | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by ATP with istaroxime | |
7WYY | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by inorganic phosphate with istaroxime | |
7WYZ | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by ATP with ouabain | |
7WZ0 | C4IX13 | Cryo-EM structure of Na+,K+-ATPase in the E2P state formed by inorganic phosphate with ouabain | |
5AVQ | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 0.75 min. | |
5AVR | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min | |
5AVS | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 3.5 min | |
5AVT | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 5 min | |
5AVU | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 7.0 min | |
5AVV | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 8.5 min | |
5AVW | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 16.5 min | |
5AVX | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 20 min | |
5AVY | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 20 min | |
5AVZ | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 55 min | |
5AW0 | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 55 min | |
5AW1 | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 85 min | |
5AW2 | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 85 min | |
5AW3 | C4IX13 | Kinetics by X-ray crystallography: Tl+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 100 min | |
5AW4 | C4IX13 | Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 1.5 min | |
5AW5 | C4IX13 | Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 2.2 min | |
5AW6 | C4IX13 | Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 5.5 min | |
5AW7 | C4IX13 | Kinetics by X-ray crystallography: Rb+-substitution of bound K+ in the E2.MgF42-.2K+ crystal after 11.3 min | |
5AW8 | C4IX13 | Kinetics by X-ray crystallography: E2.MgF42-.2RB+ crystal | |
5AW9 | C4IX13 | Kinetics by X-ray crystallography: native E2.MgF42-.2K+ crystal for Rb+ bound crystals | |
7Y45 | C4IX13 | Cryo-EM structure of the Na+,K+-ATPase in the E2.2K+ state | |
7Y46 | C4IX13 | Cryo-EM structure of the Na+,K+-ATPase in the E2.2K+ state after addition of ATP | |
6G02 | C3W6G3 | Complex of neuraminidase from H1N1 influenza virus with tamiphosphor omega-azidohexyl ester | Neuraminidase |
3NSS | C3W5S3 | The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active sites | |
3TI3 | C3W5S3 | Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with laninamivir | |
3TI4 | C3W5S3 | Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with laninamivir octanoate | |
3TI5 | C3W5S3 | Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with Zanamivir | |
3TI6 | C3W5S3 | Crystal structure of 2009 pandemic H1N1 neuraminidase complexed with oseltamivir | |
7MEM | C3W5S1 | CryoEM structure of monoclonal Fab 045-09 2B05 binding the lateral patch of influenza virus H1 HA | |
3AL4 | C3W5S1 | Crystal structure of the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus | |
3LZG | C3W5S1 | Crystal structure of a 2009 H1N1 influenza virus hemagglutinin | |
3UBE | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTc | |
3UBJ | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand LSTa | |
3UBN | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand 6SLN | |
3UBQ | C3W5S1 | Influenza hemagglutinin from the 2009 pandemic in complex with ligand 3SLN | |
3ZTN | C3W5S1 | STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H1 INFLUENZA HAEMAGGLUTININ. | |
4JTV | C3W5S1 | Crystal structure of 2009 pandemic influenza virus hemagglutinin complexed with human receptor analogue LSTc | |
4JTX | C3W5S1 | Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E | |
4JU0 | C3W5S1 | Crystal structure of 2009 pandemic influenza virus hemagglutinin mutant D225E complexed with human receptor analogue LSTc |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024